New hire bolsters FTC’s biopharma focus 

Acting FTC Chairwoman Rebecca Kelly Slaughter’s appointment of Marta Wosińska as director of the FTC’s Bureau of Economics bolsters her team with the addition of an economist with in-depth knowledge of health policy and regulation and experience at HHS, FDA and Congress.

Bringing Wosińska on board will give Slaughter intellectual horsepower to make good on her commitment to make the biopharmaceutical industry a major focus...